1. Market Research
  2. > Pharmaceutical
  3. > Drug Development Market Trends
  4. > Drug Development Analysis & Statistics in Australia, June 2019

Drug Development Analysis & Statistics in Australia, June 2019

1-28 of 28 reports

Biopsy Needles - Medical Devices Pipeline Assessment, 2019

Biopsy Needles - Medical Devices Pipeline Assessment, 2019

  • $ 2500
  • Industry report
  • February 2019

Biopsy Needles - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “Biopsy Needles - Medical Devices Pipeline Assessment, 2019" provides an overview of Biopsy ...

  • Industries : Drug Delivery, Diagnostics, Healthcare, Pharmaceutical, Drug Development
  • Countries : United States, Australia
Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2018

SummaryPharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products.The company provides products such as aridol which identify twitchy and assist ...

  • Industries : Pharmaceutical, Healthcare, Drug Development, Pathology
  • Countries : Australia, United States, World, Australasia
3-D Matrix Ltd (7777) - Product Pipeline Analysis, 2018 Update

3-D Matrix Ltd (7777) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • November 2018

Summary3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology unde ...

  • Industries : Medical Supply, Drug Development
  • Countries : Japan, Australia, Australasia
Genera Biosystems Ltd (GBI) - Product Pipeline Analysis, 2018 Update

Genera Biosystems Ltd (GBI) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • October 2018

SummaryGenera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer.The company offers RTIplex and PapType molecular diagnostic test.Its RTIplex is a multiplexed and automated ...

  • Industries : Diagnostics
  • Countries : Australia, India, United States, Australasia, World
Novotech (Australia) Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Novotech (Australia) Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryNovotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services.The organization’s services include clinical trials, data management, biostatistics ...

  • Industries : Drug Development, Pharmaceutical
  • Countries : Australia
ValiRx Plc (VAL) - Medical Equipment - Deals and Alliances Profile

ValiRx Plc (VAL) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer.The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE ...

  • Industries : Therapy
  • Countries : United Kingdom, Australia
Immutep Ltd (IMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immutep Ltd (IMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryImmutep Ltd (Immutep) is formerly known as Prima BioMed Ltd, is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases.The company provide ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States, Australia, World, Australasia
Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2018

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • September 2018

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2018SummaryAccording to the recently published report ’Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 o ...

  • Industries : Therapy, Pharmaceutical, Chronic Disease
  • Countries : World, Australia
AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2018 Update

AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • September 2018

SummaryAngioDynamics Inc (AngioDynamics) is a provider of minimally invasive medical, surgical and diagnostic devices.Its product portfolio encompasses peripheral vascular products, radiofrequency ablation ...

  • Industries : Pathology, Cancer, Pharmaceutical, Drug Delivery, Healthcare, Drug Development
  • Countries : Australia, United States
Immutep Ltd (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immutep Ltd (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2018

SummaryImmutep Ltd(Immutep) is formerly known as Prima BioMed Ltd is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases.The company’s ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States, Australia, World, Australasia
Vitamins Tests - Medical Devices Pipeline Assessment, 2018

Vitamins Tests - Medical Devices Pipeline Assessment, 2018

  • $ 2500
  • Industry report
  • July 2018

Vitamins Tests - Medical Devices Pipeline Assessment, 2018SummaryGlobalData’s Medical Devices sector report, “Vitamins Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Vitamins ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Medical Device
  • Countries : United States, Australia
Inhalable Drug Delivery - Medical Devices Pipeline Assessment, 2018

Inhalable Drug Delivery - Medical Devices Pipeline Assessment, 2018

  • $ 4000
  • Industry report
  • July 2018

Inhalable Drug Delivery - Medical Devices Pipeline Assessment, 2018SummaryGlobalData’s Medical Devices sector report, “Inhalable Drug Delivery - Medical Devices Pipeline Assessment, 2018" provides ...

  • Industries : Pharmaceutical, Drug Development, Drug Delivery, Therapy
  • Countries : Australia
A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H1 2018

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H1 2018

  • $ 3500
  • Company report
  • June 2018

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, ...

  • Industries : Therapy, Chronic Disease, Pharmaceutical, Pathology
  • Countries : Australia, United States, World
Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018

  • $ 4000
  • Industry report
  • May 2018

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018SummaryGlobalData’s Medical Devices sector report, “Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018" provides ...

  • Industries : Pharmaceutical, Drug Delivery, Drug Development
  • Countries : Australia, United States
Anti-Knock Preparation Market in Australia to 2022 - Market Size, Development, and Forecasts

Anti-Knock Preparation Market in Australia to 2022 - Market Size, Development, and Forecasts

  • $ 559
  • Industry report
  • January 2018

The report Anti-Knock Preparation Market in Australia to 2022 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for anti-knock ...

  • Industries : Drug Development
  • Countries : Australia, Australasia
Ambu AS (AMBU B) - Product Pipeline Analysis, 2017 Update

Ambu AS (AMBU B) - Product Pipeline Analysis, 2017 Update

  • $ 750
  • Company report
  • December 2017

SummaryAmbu A/S (Ambu) is a medical device company with a focus on anesthesia, patient monitoring and diagnostics and emergency care markets. It manufactures and markets life supporting devices, catering ...

  • Countries : Australia, United States, Australasia
A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H2 2017

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • December 2017

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, ...

  • Industries : Therapy, Pharmaceutical, Chronic Disease, Pathology, Drug Development
  • Countries : World, Australia, United States, Australasia
Prima BioMed Ltd (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Prima BioMed Ltd (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2017

SummaryPrima BioMed Ltd (Prima BioMed) is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. The company’s products are based on LAG-3 ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States, Australia, World, Australasia
Australia Clinical Chemistry Market Outlook to 2024

Australia Clinical Chemistry Market Outlook to 2024

  • $ 4995
  • Industry report
  • November 2017

Australia Clinical Chemistry Market Outlook to 2024SummaryGlobalData’s new report, Australia Clinical Chemistry Market Outlook to 2024, provides key market data on the Australia Clinical Chemistry market. ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Medical Device
  • Countries : Australia, Australasia, Oceania
Herpes Simplex Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Herpes Simplex Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • September 2017

Herpes Simplex Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Herpes Simplex Virus Diagnostic Tests - Medical Devices Pipeline ...

  • Industries : Healthcare, Pathology, Diagnostics
  • Countries : Australia
Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • September 2017

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, ...

  • Industries : Diagnostic Imaging, Medical Device, Drug Development
  • Countries : United States, Australia, North America
Neurosurgical Products - Medical Devices Pipeline Assessment, 2017

Neurosurgical Products - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • August 2017

Neurosurgical Products - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Neurosurgical Products - Medical Devices Pipeline Assessment, 2017" provides an ...

  • Industries : Drug Development, Health Services, Pharmaceutical, Healthcare
  • Countries : Australia, United States
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H2 2016

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • November 2016

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H2 2016SummaryGlobal Markets Direct’s, ‘70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H2 ...

  • Industries : Therapy, Pharmaceutical, Drug Development, Health Services
  • Countries : United States, World, United Kingdom, Australia
Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016

Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016

Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016SummaryGlobal Markets Direct’s, ‘Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta ...

  • Industries : Therapy, Cancer, Oncology
  • Countries : United States, Australia, World, Australasia
Sphingosine 1-Phosphate Receptor 1 (S1P Receptor 1 or Endothelial Differentiation G-Protein Coupled Receptor 1 or Sphingosine 1-Phosphate Receptor Edg-1 or CD363 or S1PR1 or CHEDG1 or EDG1) - Pipeline Review, H1 2016

Sphingosine 1-Phosphate Receptor 1 (S1P Receptor 1 or Endothelial Differentiation G-Protein Coupled Receptor 1 or Sphingosine 1-Phosphate Receptor Edg-1 or CD363 or S1PR1 or CHEDG1 or EDG1) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • June 2016

Sphingosine 1-Phosphate Receptor 1 (S1P Receptor 1 or Endothelial Differentiation G-Protein Coupled Receptor 1 or Sphingosine 1-Phosphate Receptor Edg-1 or CD363 or S1PR1 or CHEDG1 or EDG1) - Pipeline ...

  • Industries : Pathology, Pharmaceutical, Medical Biotechnology
  • Countries : United States, World, Australia
MediPoint: Renal Denervation - Global Analysis and Market Forecasts

MediPoint: Renal Denervation - Global Analysis and Market Forecasts

  • $ 5995
  • Industry report
  • April 2016

MediPoint: Renal Denervation - Global Analysis and Market ForecastsSummaryRenal denervation catheters are categorized into the following: radiofrequency (RF) catheters, ultrasound catheters, and micro-injection ...

  • Industries : Pharmaceutical
  • Countries : World, Australia, North America
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

  • $ 2199
  • Industry report
  • February 2016

INTRODUCTIONPeptide therapeutics, due to their numerous advantages such as high selectivity, stability, efficacy, safety, bioavailability and tolerability offer a number of benefits over other therapeutic ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : Australia, United States, North America
The Australian Contract Research Organization Market 

The Australian Contract Research Organization Market 

  • $ 1500
  • Industry report
  • August 2015

The Australian Contract Research Organization Market : Early Phase Clinical Trials are Set to Drive the Australian CRO MarketThis research service presents an overview and analysis of the Australian contract ...

  • Industries : Drug Development
  • Countries : Australia, Australasia



ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on